Driehaus Capital Management’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-52,679
Closed -$11.5M 466
2020
Q3
$11.5M Sell
52,679
-24,035
-31% -$5.09M 0.24% 117
2020
Q2
$14.6M Sell
76,714
-24,702
-24% -$4.33M 0.36% 87
2020
Q1
$15.7M Buy
101,416
+46,550
+85% +$5.42M 0.53% 55
2019
Q4
$4.59M Buy
54,866
+13,466
+33% +$1.02M 0.12% 198
2019
Q3
$2.8M Buy
+41,400
New +$2.72M 0.09% 218
2019
Q1
Sell
-144,524
Closed -$7.16M 481
2018
Q4
$7.16M Sell
144,524
-196,115
-58% -$12M 0.31% 95
2018
Q3
$29.4M Buy
340,639
+74,074
+28% +$5.28M 0.91% 13
2018
Q2
$15.5M Sell
266,565
-47,241
-15% -$2.31M 0.52% 35
2018
Q1
$12.6M Buy
313,806
+169,466
+117% +$6.4M 0.45% 47
2017
Q4
$5.03M Sell
144,340
-113,403
-44% -$3.77M 0.19% 147
2017
Q3
$8.54M Sell
257,743
-141,549
-35% -$4.64M 0.33% 75
2017
Q2
$13.9M Buy
399,292
+142,836
+56% +$4.16M 0.51% 35
2017
Q1
$6.41M Buy
+256,456
New +$5.34M 0.22% 104

Other funds holding TDOC

Driehaus Capital Management's TDOC Position: Q4 2020 in Review

Driehaus Capital Management sold out of Teladoc Health (TDOC) in Q4 2020, closing a stake of 52,679 shares — an estimated $11.5M sold.

Driehaus Capital Management first reported a position in TDOC in Q1 2017 and held it in 13 quarters. The position peaked at $29.4M in Q3 2018. 901 funds tracked by Wall St. Rank hold TDOC as of Q4 2020.

  • Driehaus Capital Management reported no remaining Teladoc Health position as of Q4 2020 after selling out during the quarter.
  • Driehaus Capital Management sold 52,679 Teladoc Health shares in Q4 2020, an estimated $11.5M.
  • Driehaus Capital Management first reported a position in Teladoc Health in Q1 2017 and held it in 13 quarters.
  • Driehaus Capital Management's Teladoc Health position peaked at $29.4M in Q3 2018.
  • 901 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2020.

Based on Driehaus Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.